
Sign up to save your podcasts
Or


Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.
By Chemistry World4.7
183183 ratings
Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.

3,198 Listeners

543 Listeners

819 Listeners

2,365 Listeners

327 Listeners

6,584 Listeners

3,370 Listeners

382 Listeners

150 Listeners